Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats
Erythropoietin (EPO) has been shown to protect the heart against acute myocardial infarction in pre-clinical studies, however, EPO failed to reduce infarct size in clinical trials and showed significant safety problems. Here, we investigated cardioprotective effects of two selective non- erythropoie...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
Academic Press
2016
|
| Sorozat: | PHARMACOLOGICAL RESEARCH
113 No. Part A |
| doi: | 10.1016/j.phrs.2016.08.013 |
| mtmt: | 3101388 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/11799 |